NCT05433246

Effects of Massage Therapy on Peripheral Neuropathy and Quality of Life

Effect of Massage Therapy on Peripheral Neuropathy and Life Quality of Colorectal Cancer wıth Patient Receiving Chemotherapy
Fatma Arikan·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov
Study focus
Drug/Device/Intervention
Massage therapy group
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Fatma Arikan
Funder
Akdeniz University
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2012
End date
May 01, 2013
Enrollment
52 participants
Primary outcome

Peripheral Neuropathy Evaluation Form,Self-Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (S-LANSS),MD Anderson Symptom Inventory,European Organisation for Research and Treatment of Cancer-Quality of Life Scale,American National Cancer Institute Cancer Therapy Evaluation Program Common Toxicity Criteria, Version 2.0

Summary

The aim of this randomized controlled experimental study was to determine the effect of
 massage applied to colorectal cancer patients receiving chemotherapy on peripheral neuropathy
 and quality of life.

ICD-10 classifications
Drug-induced polyneuropathyParaneoplastic neuromyopathy and neuropathyPolyneuropathy due to other toxic agentsIdiopathic peripheral autonomic neuropathyIdiopathic progressive neuropathy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05433246
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05433246 through Pure Global AI's free database. This phase not specified trial is sponsored by Fatma Arikan and is currently Completed. The study focuses on Chemotherapy-induced Peripheral Neuropathy. Target enrollment is 52 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.